Antifreeze peptides, their design methods, applications, low-temperature structure prediction methods, and cell cryopreservation solutions

By designing ice-binding sites and using low-temperature energy minimization methods, we synthesized antifreeze peptides with highly efficient ice-suppressing capabilities, solving the cost and purity issues of natural antifreeze proteins in applications, and achieving highly efficient ice-suppressing effects in cell cryopreservation solutions.

CN120708702BActive Publication Date: 2026-11-17TIANJIN UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510684935.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-05-26
Publication Date
2026-11-17
Estimated Expiration
2045-05-26

AI Technical Summary

Technical Problem

Existing technologies for natural antifreeze proteins suffer from problems such as high cost, difficulty in ensuring purity, difficulty in verifying safety, and inability of structure prediction software to match antifreeze function in practical applications. Furthermore, research on de novo design of antifreeze peptides is still in its infancy.

Method used

By designing ice-binding sites and regulating the distance between amino acid residues, the structure of antifreeze peptides was predicted using a low-temperature energy minimization method. Antifreeze peptides with high ice-inhibiting ability were synthesized, and a cell cryopreservation protection solution was provided.

Benefits of technology

This method effectively inhibits ice crystal growth, significantly improves the biocompatibility and ice-inhibiting ability of antifreeze peptides, and provides a precise method for predicting low-temperature structures, suitable for cryopreservation of cells.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120708702B_ABST
    Figure CN120708702B_ABST
Patent Text Reader

Abstract

This invention belongs to the field of biomaterials preparation, specifically relating to an antifreeze peptide, its design method, applications, low-temperature structure prediction method, and cell cryopreservation solution. The antifreeze peptide includes binding sites that bind to ice crystals; these binding sites are one or more of glutamate (E.g., Glu), aspartate (D.g., ASP), lysine (K.g., Lys), arginine (R.g., Arg), and tyrosine (Y.g., Tyr). This invention overcomes the evolutionary limitations of natural antifreeze proteins, obtaining the strongest ice-binding residue site E, whose ice-binding energy is four times that of the threonine (T) ice-binding residue of natural antifreeze proteins. By combining the ice-binding site with known antifreeze peptides, a de novo design method for antifreeze peptides is obtained. This method matches antifreeze peptides with different ice-binding site distances, unlike the residue distances of natural antifreeze proteins, and designs and synthesizes a series of antifreeze peptides with high ice-inhibiting ability and good biocompatibility. Simultaneously, this invention provides a method for minimizing energy at low temperatures for accurately predicting the structure of antifreeze peptides at low temperatures.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biomaterial preparation, specifically relating to an antifreeze polypeptide and its design method, application, low-temperature structure prediction method, and cell cryopreservation solution. Background Technology

[0002] To adapt to cold environments, organisms have developed a class of proteins with antifreeze functions during long-term natural evolution. These proteins are called antifreeze proteins (AFPs) to protect the body from freezing temperatures. The types, structures, and sequences of antifreeze proteins vary depending on species diversity and living environment. Currently known antifreeze proteins come from a wide range of sources, including fish, insects, plants, fungi, and bacteria.

[0003] Antifreeze proteins can regulate water molecule nucleation and ice crystal growth. Compared to other antifreeze molecules (such as dimethyl sulfoxide (DMSO) and glycerol), antifreeze proteins possess unique non-colligable regulatory capabilities, enabling highly efficient ice suppression even at low concentrations. Therefore, antifreeze proteins have become a research hotspot in fields such as cell cryopreservation and food preservation. However, with the deepening research on antifreeze proteins, natural antifreeze proteins face many challenges in practical applications. First, natural antifreeze proteins are mainly found in organisms in some high-altitude, cold regions, and at extremely low concentrations, resulting in very high costs for purifying these proteins from organisms, severely limiting their large-scale industrial application. Although microbial fermentation can achieve large-scale production of antifreeze proteins, it is difficult to guarantee purity and safety. Second, natural antifreeze proteins have potential toxicity and immunogenicity, requiring further safety verification through animal models before application.

[0004] With the development of artificial intelligence, de novo design and construction of novel protein structures based on amino acid sequences has become a significant breakthrough in the field of protein engineering. However, computational tools for antifreeze proteins are still in their early stages of development, primarily due to the following reasons: First, antifreeze proteins have only been known for 65 years, and related research is still in its infancy; second, natural antifreeze proteins are widely sourced, structurally diverse, and lack uniform structural or sequence characteristics, leading to unclear structure-activity relationships; third, in the field of protein design, the accuracy of structure prediction software is crucial, but current protein structure prediction software can only predict room-temperature structures and cannot match the functions of antifreeze proteins. Currently, research on de novo design of antifreeze proteins without relying on the structure and sequence of natural antifreeze proteins remains lacking.

[0005] Antifreeze peptides are a class of peptides composed of short amino acid sequences. Because they can also match the ice crystal lattice and inhibit ice crystal growth, they are the most promising alternatives to antifreeze proteins. Compared to antifreeze proteins, antifreeze peptides have lower immunogenicity, higher designability, and can be mass-produced and purified, providing a solution to current antifreeze problems. Currently, the acquisition of antifreeze peptides mainly relies on extracting fragments from natural proteins or screening peptide libraries using phage display technology; de novo design of antifreeze peptides remains a challenging problem that needs to be overcome. Summary of the Invention

[0006] The purpose of this invention is to overcome the shortcomings of the prior art and provide an antifreeze polypeptide, its design method, application, low-temperature structure prediction method, and cell cryopreservation solution.

[0007] To achieve the above objectives, the technical solution adopted by the present invention is as follows:

[0008] A method for designing antifreeze peptides, which designs the desired antifreeze peptides by defining ice-binding sites and the distances between ice-binding sites;

[0009] The ice-binding site is one or more of the following: glutamic acid E (Glu), aspartic acid D (ASP), lysine K (Lys), arginine R (Arg), and tyrosine Y (Tyr).

[0010] The ice-binding site is a site that binds to the secondary facet of an ice crystal; the ice-binding site includes one or more glutamate E (Glu) and aspartic acid D (ASP); preferably, it includes two or three glutamate E (Glu).

[0011] The distance between ice-binding sites is called the site distance. The site distance regulation method involves predicting the antifreeze peptide structure using a low-temperature energy minimization method and regulating other amino acid residues outside the ice-binding sites to achieve the desired site distance.

[0012] The preferred site distance is... One of them, more preferably

[0013] The ice-binding sites are located on the same plane, F-plane, and other amino acid residues will not appear on the F-plane or its extended plane; multiple ice-binding sites are equidistant from the oxygen atoms on the ice crystal surface.

[0014] The present invention also includes an antifreeze polypeptide obtained by the design method described above, containing an ice-binding site, wherein the ice-binding site is one or more of glutamic acid E, aspartic acid D, lysine K, arginine R, and tyrosine Y.

[0015] Preferably, it has at least one of the following sequences; SEQ NO.1 ECENSKDCFEAQ; SEQ NO.2 EVEGSNNEVEGNDN; SEQ NO.3 EVEASTNCYKAT; SEQ NO.4 ECEDSTNCYKAT; SEQ NO.5 ECEDSGNCYKAT; SEQ NO.6 ECEASTNCYKAT; SEQ NO.7 EVEADSTNCYKAT; SEQ NO.8 AVDAGEGEDELIIGGDVSG; SEQ NO.9 AVDAGECEDELIIGGDVSG.

[0016] This invention also includes a method for predicting the low-temperature structure of the antifreeze peptide, which uses a low-temperature energy minimization method to predict the structure; specifically, it includes the following steps: placing the antifreeze peptide in a simulated box filled with water molecules, and maintaining electroneutrality by adding an ion neutralization system; then performing a low-temperature energy minimization simulation, with a temperature range of 220-298K; preferably 260K.

[0017] The present invention also includes an application of the aforementioned antifreeze peptide in the cryopreservation of cells.

[0018] The present invention also includes a cell cryopreservation solution comprising the aforementioned antifreeze peptide.

[0019] Compared with the prior art, the beneficial effects of the present invention are:

[0020] This invention overcomes the evolutionary limitations of natural antifreeze proteins, obtaining ice-binding sites, especially the strongest ice-binding site, glutamic acid (E), whose ice-binding energy is four times that of the threonine (T) ice-binding residue in natural antifreeze proteins. By combining these ice-binding sites with known antifreeze peptides, a de novo method for designing antifreeze peptides was developed. This method matches antifreeze peptides with different site distances, unlike the residue distances of natural antifreeze proteins, and designs and synthesizes a series of antifreeze peptides with highly efficient ice-inhibiting capabilities and good biocompatibility. Simultaneously, this invention provides a method for minimizing energy at low temperatures for accurately predicting the structure of antifreeze peptides at low temperatures. Attached Figure Description

[0021] Figure 1 A diagram showing the binding affinity between 20 natural amino acids and ice crystals;

[0022] Figure 2 The diagram shows the prism lattice of ice crystals and the analysis of lattice distances.

[0023] Figure 3 Figure showing the results of verifying the antifreeze ability of ice-binding site E;

[0024] Figure 4 This is a diagram showing the predicted structure of antifreeze peptides at different temperatures;

[0025] Figure 5 Figure 1 shows the morphology (a) and growth rate (b) of ice crystals in a 5 mg / mL polypeptide solution (with a supercooling of 0.06 °C).

[0026] Figure 6 The structure of the antifreeze peptide forming an ice-binding surface with three ice-binding sites (a), a schematic diagram of lattice matching between the peptide and ice crystals (b), and an ice crystal morphology diagram (c);

[0027] Figure 7 Biocompatibility diagram of a novel antifreeze peptide validated in animal experiments. Detailed Implementation

[0028] To enable those skilled in the art to better understand the technical solution of the present invention, the present invention will be further described in detail below with reference to the accompanying drawings and preferred embodiments.

[0029] Example 1: Selection of ice-binding sites for antifreeze peptides

[0030] The three-dimensional structures of 20 natural amino acids (alanine Ala, cysteine ​​Cys, aspartic acid Asp, glutamic acid Glu, phenylalanine Phe, methionine Met, asparagine Asn, proline Pro, glutamine Gln, arginine Arg, glycine Gly, histidine His, isoleucine Ile, lysine Lys, leucine Leu, serine Ser, threonine Thr, valine Val, tryptophan Trp, and tyrosine Tyr) were obtained using Gaussian software.

[0031] The simulations were performed using the TIP / 4P ice-water model and the Charmm 36 force field. All simulations were implemented using Gromacs software.

[0032] Specifically, the ice layer was constructed using the Genice software. The resulting .gro file was converted to a .pdb file using the EditConf program included with Gromacs, ultimately yielding an ice layer measuring 9.4nm × 5.1nm × 10.7nm. This ice layer was placed in the center, and water molecules were added to both ends of the ice layer using Packmol software, with one ice layer and 13,000 liquid water molecules, thus constructing the simulation box. Finally, the EditConf command was used to convert the resulting .pdb file back to a .gro file, resulting in the simulation box file icebox.gro, composed of a water layer-ice layer-water layer configuration.

[0033] Under a Charmm36 force field, the PDB structure file of the target molecule was processed using the pdb2gmx program included in Gromacs software, and a Gro file was output. The TIP / 4P ice-water molecule model was selected. The Packmol program was used to randomly place 15 target amino acid molecules within the water molecules on the upper layer of ice crystals, with the global atomic spacing set to be no less than [value missing]. The output file is a15.pdb. The resulting pdb file is converted to a gro file using the editconf program included in Gromacs software, resulting in a15.gro. This a15.gro file is then merged with icebox.gro and saved as b.gro. The simulation parameters, conformations, and force fields are integrated into a complete input file using the grompp command. The program is then started using the mdrun command, performing energy minimization, NPT equilibrium, and finally MD simulation. Temperature coupling is achieved using the V-rescale method, and pressure coupling using the Parrinello-Rahman method. A cutoff radius of 1 nm is used, and periodic boundary conditions are applied in three-dimensional space with a time step of 2 fs and a duration of 100 ns.

[0034] After the molecular dynamics simulation concluded, all water molecules inside the simulation chamber condensed into ice molecules. Hydrogen bond interaction data for the system, amino acid, side chain, and water systems were then exported sequentially. An ndx index file was generated using the `make_ndx` command, and the trr trajectory file was converted to xtc format using the `trjconv` command. The tpr run input file was modified using the `convert` command, and an edr energy file was obtained using the `mdrun` command. The energy was analyzed using the `energy` command, and an xvg two-dimensional icon file was output for subsequent analysis. Finally, the `index.xvg` file was renamed to the corresponding filename, ultimately yielding the system hydrogen bond interactions (Es), amino acid hydrogen bond interactions (Ea), and ice molecule hydrogen bond interactions (Ei).

[0035] The formula for calculating the hydrogen bond interaction E(ai) between amino acids and ice crystals is:

[0036] E(ai) = Es - Ea - Ei;

[0037] To eliminate the influence of the binding energy of the C-terminal carboxyl group and N-terminal amino group of amino acids, G(glycine) was selected as the calculation background for energy subtraction. G(glycine) contains only -H groups in its side chain and serves only as a flexible rotation site in natural antifreeze proteins. The final calculation results are as follows: Figure 1 The strongest ice-binding site E (Glu) was obtained, along with the aspartic acid D (ASP), lysine K (Lys), arginine R (Arg), and tyrosine Y (Tyr) in descending order.

[0038] Therefore, it is believed that antifreeze peptides containing ice-binding sites that bind to ice crystals can inhibit ice crystal growth; specifically, the binding sites are one or more of glutamic acid E (Glu), aspartic acid D (ASP), lysine K (Lys), arginine R (Arg), and tyrosine Y (Tyr).

[0039] Example 2: Measurement of ice crystal lattice distance

[0040] For a single ice crystal, it has multiple crystal faces, including the basal face {0001}, the primary facet {1010}, the secondary facet {1120}, and the pyramidal facet {2021}. Water molecules are arranged regularly through hydrogen bonds to form ice, and the spatial distance between oxygen atoms in the water molecule varies with different crystal facet angles.

[0041] After constructing an ice layer using Genice software, the ice layer was opened using VMD software. An orthographic view was selected, and the distance command was used to measure the distance between oxygen atoms on different crystal faces separated by different lattice spaces. To explore the rules governing the disruption of ice-like molecular architecture by the ice lattice span of antifreeze peptides and to obtain the optimal matching distance between ice binding sites, antifreeze peptides matching different numbers of lattice spaces were designed, using the secondary facet morphology of ice crystals as the research object. For example... Figure 2 As shown, on the secondary facets of ice crystals, there are various antifreeze peptide ice-binding residues that can be matched with ice crystal distances.

[0042] Example 3: Construction of a Low-Temperature Energy Minimization System

[0043] The three-dimensional structure of the antifreeze peptide was obtained using PEPFOLD3 prediction software. Simulations were performed using the SPC water molecule model and the GROMOS96 54a7 force field. All simulations were implemented using GROMACS software. A cubic box was constructed around the designed antifreeze peptide using editconf software, with the box edge 0.6 nm from the peptide edge and the antifreeze peptide located at the center of the box. Water molecules were then filled into the box using solvate software. If the peptide chain carried a positive or negative charge, Cl was added to the system using genion software. - / Na +To ensure the system remains electrically neutral, simulation parameters, conformations, and force fields were integrated using the `grompp` command to form a complete input file. The program was then started using the `mdrun` command, sequentially performing energy minimization, restricted kinetic simulation, and finally MD simulation. Electrostatic interactions were simulated using the Verlet and PME algorithms, while van der Waals interactions were simulated using the cut-off algorithm. A cutoff radius of 1 nm was used, and periodic boundary conditions were applied in three-dimensional space. A 5000-step energy minimization using the conjugate gradient method was employed to reduce unreasonable structures caused by molecular placement. Restricted kinetic simulations were then performed on the peptide to ensure that the peptide structure did not significantly change before water relaxation, thus preventing potential conformational disruption. A 100 ps calculation was performed using the leapfrog algorithm with a time step of 2 fs, and equilibrium was established at 1 bar, 260 K, or 298 K; 260 K was preferred. Temperature coupling was achieved using the V-rescale method, and pressure coupling was achieved using the Berendsen method. Finally, a 20 ns MD simulation was performed under these temperature and pressure conditions with a time step of 2 fs. Temperature coupling was performed using the V-rescale method, and pressure coupling was performed using the Parrinello-Rahman method to predict the structure of the antifreeze peptide at low temperature.

[0044] Example 4: Antifreeze ability of ice binding site E

[0045] TCT and TVT are antifreeze peptides derived from natural mealworm and ryegrass antifreeze proteins, respectively, which bind to ice crystals via hydrogen bonds at the T binding site. Without altering the secondary structure, this invention replaced the T binding site in TCT and TVT peptides with E to investigate the effect of the ice binding site on the ability of the antifreeze peptides to inhibit ice crystal growth. Two novel antifreeze peptides, ECE and EVE, were obtained; their specific sequences are shown in Table 1.

[0046] Table 1

[0047]

[0048] like Figure 3 As shown in Figure a, the novel antifreeze peptide has a similar secondary structure to the original antifreeze peptide; therefore, the difference in antifreeze properties originates entirely from changes in the amino acids at the ice-binding sites. Figure 3 As shown in Figure b, the 0.25% wt concentration of ECE antifreeze peptide inhibited the growth rate of single ice crystals to 7.06 μm / s, representing an inhibition rate increase of approximately 200% compared to the TCT peptide. The 0.25% wt concentration of EVE antifreeze peptide inhibited the growth rate of single ice crystals to 10.78 μm / s, representing an inhibition rate increase of approximately 145% compared to the TVT peptide. Experiments demonstrate that, at the same concentration and with the same secondary structure, the ice-binding site E exhibits significantly stronger ice crystal binding ability than the natural ice-binding site T, making it a more powerful ice crystal binding site suitable for the design and development of novel antifreeze peptides.

[0049] Example 5: De novo design of antifreeze peptides

[0050] Based on the low-temperature energy minimization method for antifreeze peptides in Example 3, and using the ECE peptide in Example 4 as a template, the structure was predicted by regulating other amino acids except for the ice-binding sites and using the low-temperature energy minimization method, such that the distance between the two ice-binding sites was respectively... (The sequence is shown in Table 2), and its structure is as follows: Figure 4 As shown.

[0051] Table 2

[0052]

[0053] Based on the low-temperature energy minimization method for antifreeze peptides in Example 3, using the natural antifreeze peptide AVD as a template, and combining the strongest ice crystal binding site with the site matching distance, three ice-binding sites (glutamic acid E) are added to the antifreeze peptide. The structure of the antifreeze peptide is regulated by controlling the amino acid residues on both sides of the ice-binding sites, ensuring that the three ice-binding residues are located in the same plane F, while other amino acid residues do not appear on the F plane or its extended planes, guaranteeing that there is no steric hindrance in the binding between the ice-binding residues on the F plane and the ice crystal. Simultaneously, the distance between each pair of the three ice-binding sites is crucial for the specific adsorption of the antifreeze peptide onto the crystal plane; the distance between the three ice-binding sites should be the same as the distance between the three O atoms on the ice crystal surface, ensuring that the antifreeze peptide can only specifically adhere to a single crystal plane.

[0054] Based on the above design principles and methods, two antifreeze peptides were designed, and their sequences are shown in Table 3.

[0055] Table 3

[0056]

[0057] like Figure 6 As shown, both E-7 and E-8 peptides contain three ice-binding sites E located in the same plane. Furthermore, the spacing between the three ice-binding sites of E-7 and E-8 is the same as the spacing between the three O atoms on the secondary facet of the ice crystal, achieving synergy between the ice-binding sites.

[0058] Results of de novo design of antifreeze peptides and testing of their ice-inhibiting ability:

[0059] 1. Test on ability to inhibit ice crystal growth

[0060] A nano-osmometer was used for testing. 5 mg of the antifreeze peptide sample was dissolved in 1 mL of ultrapure water to obtain a peptide aqueous solution with a concentration of 5 mg / mL. The pure aqueous solution was used as a negative control. A disc with six sampling wells was sealed with oil on one side, oil-sealed side down, and placed at the designated location for nano-measurement. One bright and easily observable well was selected for observation. The sample solution was gently dripped into this well using a sampler, ensuring complete coverage. The growth rate of individual ice crystals in the peptide aqueous solution was controlled using a nano-osmometer: the target temperature of the nano-osmometer was first set to -20℃, and the temperature limit was controlled at 0.35℃ / s, allowing the sample solution to freeze rapidly. When the circular spot on the software screen changed from bright to dark and then stopped changing, the sample was considered completely frozen. The target temperature was then set to -0.80℃. When the solution melted down to the last few ice crystals, the temperature rate was reduced to 0.01℃ / s. The melting point of the ice crystal was determined when only one small, round ice crystal remained and its size no longer changed. The temperature was then reduced by 0.06℃, and the morphology and growth process of the ice crystal were recorded. The growth rate of the ice crystal was also measured. The results are as follows: Figure 5 a, Figure 6 As shown in c, Figure 5 In the figure, b represents the ice crystal growth rate results for E-1, E-2, E-3, E-4, and E-5. Figure 6 Figure a shows the secondary structure diagram of antifreeze peptides E-7 and E-8; Figure 6 Figure b shows the lattice distance analysis diagram of the binding of E-8 peptide with ice crystals.

[0061] like Figure 5 and Figure 6 As shown, the designed antifreeze peptides can significantly inhibit the growth rate of ice crystals. Meanwhile, Figure 5 The results showed that the ability of antifreeze peptides to inhibit ice crystal growth was related to the distance between their residue sites. When the site spacing was... At that time, the antifreeze peptides showed the strongest ability to inhibit ice crystal growth, reducing the growth rate of a single ice crystal to 1.74 μm / s. Figure 6 The results showed that peptides E-7 and E-8 could specifically recognize ice crystal surfaces and possessed a strong ability to modify ice crystal morphology. In a 0.25% (w / w) solution of the antifreeze peptides, at a supercooling ΔT = 0.06℃, disc-shaped single ice crystals were first modified into regular hexagons, and then burst after 5 seconds. This indicates that the antifreeze peptides E-7 and E-8 have a thermal hysteresis effect, which is the first report of antifreeze peptides with thermal hysteresis activity. Simultaneously, the growth rate of ice crystals after bursting was tested. 0.1% wt of the antifreeze peptides E-7 and E-8 could inhibit the ice crystal growth rate to 3.2 μm / s and 2.8 μm / s, respectively, which was 4 times lower than that of the natural antifreeze peptide AVD with the same amino acid number.

[0062] 2. Test on the ability of antifreeze peptides to protect cells during cryopreservation

[0063] Cryopreservation solution E7-CPA: a culture medium solution containing 6% betaine and 0.5% antifreeze peptide E-7.

[0064] AVD-CPA cryopreservation solution: a culture medium solution containing 6% betaine and 0.5% antifreeze peptide AVD.

[0065] Mouse adipose-derived stem cells (ADSCs), mouse fibroblasts (NIH / 3T3), and human lung adenocarcinoma cells (GLC-82) were cultured in a 37°C, 5% CO2 incubator. After separating the cells with trypsin, they were washed twice with phosphate-buffered saline (PBS) and collected by centrifugation. Subsequently, 1 mL of cryopreservation buffer was added to cryovials, and the cell suspension was adjusted to 1 × 10⁻⁶ cells / mL. 6 The final density of cells / mL was determined, and the cryovials were immediately immersed in liquid nitrogen for cryopreservation. After thawing in a 37°C water bath, the cells were washed twice with PBS, and cell viability was assessed using a live / dead staining assay kit or flow cytometry.

[0066] Red blood cell (RBC) suspensions were stored at 4°C, centrifuged, and washed three times with PBS before use. Then, 20 μL of the RBC suspension was added to 750 μL of cryopreservation solution and mixed thoroughly in cryovials. The cryovials were then directly immersed in liquid nitrogen (-196°C) for cryopreservation. PBS solution containing RBCs and deionized water were used as positive and negative controls, respectively. After thawing the cells in a water bath, the samples were centrifuged, and 100 μL of the supernatant was transferred to a 96-well plate. Hemoglobin absorbance was measured at 540 nm. The detected samples, positive controls, and negative controls were named A, A0, and A1, respectively.

[0067] Red blood cell recovery rate (%) = (A-A1) / (A0-A1)×100%;

[0068] like Figure 7 As shown, ADSCs preserved with cryopreservatives containing antifreeze peptide E-7 and betaine ( Figure 7 (a, b) NIH / 3T3 ( Figure 7 c, d), GLC-82 ( Figure 7 (e, f) and RBCs ( Figure 7 The survival rate of different cell types in the medium (g) ranged from over 90%, and the thawed cells maintained normal cell morphology and function. Figure 7 (as shown in h).

[0069] In summary, this invention overcomes the evolutionary limitations of natural antifreeze proteins, obtaining ice-binding sites, especially the strongest ice-binding site, glutamic acid (E), whose ice-binding energy is four times that of the ice-binding residue threonine (T) of natural antifreeze proteins. By combining ice-binding sites with known antifreeze peptides, a de novo method for designing antifreeze peptides was obtained. This method matches antifreeze peptides with different site distances, unlike the residue distances of natural antifreeze proteins, and designs and synthesizes a series of antifreeze peptides with highly efficient ice-inhibiting capabilities and good biocompatibility. Simultaneously, this invention provides a method for minimizing energy at low temperatures for accurately predicting the structure of antifreeze peptides at low temperatures.

[0070] The above description is only a preferred embodiment of the present invention. It should be noted that for those skilled in the art, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be considered within the scope of protection of the present invention.

Claims

1. A method for designing antifreeze peptides, characterized in that, The desired antifreeze peptide, including the binding sites that bind to ice crystals, is designed by defining the ice-binding sites and the distances between them. Using a known antifreeze peptide as a template, the desired antifreeze peptide is obtained by replacing the binding sites of the known antifreeze peptide with the aforementioned binding sites. The ice-binding sites include two or three glutamate E (Glu) sites; The ice-binding sites are sites that bind to the secondary facets of ice crystals; The distance between ice-binding sites is called the site distance. The site distance regulation method is as follows: predict the structure of the antifreeze peptide by minimizing the low-temperature energy and regulate other amino acid residues outside the ice-binding sites so that the site distance is 4.6 Å-11.2 Å. The binding sites are located on the same plane, F-plane, and other amino acid residues will not appear on the F-plane or its extended plane; multiple binding sites are equidistant from the oxygen atoms on the ice crystal surface.

2. An antifreeze polypeptide obtained by the design method of claim 1, characterized in that, Having at least one of the following sequences; SEQ NO.1 ECENSKDCFEAQ; SEQ NO.2 EVEGSNNEVEGNDN; SEQ NO.3 EVEASTNCYKAT; SEQ NO.4 ECEDSTNCYKAT; SEQ NO.5 ECEDSGNCYKAT; SEQ NO.6 ECEASTNCYKAT; SEQ NO.7 EVEADSTNCYKAT; SEQ NO.8 AVDAGEGEDELIIGGDVSG; SEQ NO.9 AVDAGECEDELIIGGDVSG.

3. A method for predicting the low-temperature structure of antifreeze peptides as described in claim 2, characterized in that, The structure was predicted using a low-temperature energy minimization method, which specifically included the following steps: placing the antifreeze peptide in a simulated box filled with water molecules and maintaining electroneutrality by adding an ion neutralization system; then performing a low-temperature energy minimization simulation in the temperature range of 220-298K.

4. The application of the antifreeze polypeptide according to claim 2, characterized in that, It is used for cryopreservation of biological samples.

5. A cell cryopreservation solution, characterized in that, Includes the antifreeze polypeptide according to any one of claims 2.